Sarcomeric TPM3 expression in human heart and skeletal muscle

Area of Science:

• Molecular Biology
• Protein Expression Analysis
• Human Physiology

Background:

• Four tropomyosin (TPM) genes (TPM1-4) are known in mammals.
• TPM3α is a known TPM3 isoform, but its expression in human hearts is unclear.
• Tropomyosin proteins are crucial for muscle contraction and cellular structure.

Purpose of the Study:

• To clone and characterize novel TPM3 isoforms from human heart and skeletal muscle.
• To investigate the expression patterns of TPM3 isoforms and other TPM proteins in human fetal and adult hearts, and skeletal muscle.
• To establish the presence and relative abundance of different TPM proteins in these tissues.

Main Methods:

• Cloning of TPM3 transcripts from human tissues.
• Quantitative reverse transcription PCR (qRT-PCR) for transcript expression analysis.
• Western blotting and Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) for protein expression and identification.

Main Results:

• Four TPM3 isoforms (TPM3α, TPM3ν, TPM3ξ, TPM3ο) were identified, with TPM3ν and TPM3ο being alternatively spliced variants.
• All four TPM3 transcripts were expressed in both heart and skeletal muscle.
• TPM3 protein expression was higher in fetal hearts and adult skeletal muscle compared to adult hearts.
• TPM1 was dominant in adult hearts, TPM2 in skeletal muscle, and TPM4 was not detected in hearts.

Conclusions:

• Novel TPM3 isoforms and their transcripts are expressed in human heart and skeletal muscle.
• Differential expression of TPM proteins exists between fetal and adult hearts, and in skeletal muscle.
• The functional significance of these varying tropomyosin expression levels requires further investigation.